Clinical Trials Logo

Anal Carcinoma clinical trials

View clinical trials related to Anal Carcinoma.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03469596 Completed - Anal Carcinoma Clinical Trials

Evaluation by MRI of Anal Canal Cell Carcinoma: is There Predictive Factor?

Start date: April 1, 2017
Phase:
Study type: Observational

Anal canal cell carcinoma is a very rare cancer but well treated. If the morphological test are well established in the initial evaluation, it's not the case of the follow up evaluation particularly by MRI.About 1/3 of patient decline with metastatic relapse during the follow up of these patients.It appears that clinical regression seen precociously is a predictive factor of survival without relapse. But there 's no study confirming that point. This context takes us to evaluate if there is a predictive factor in MRI to final clinical result.

NCT ID: NCT00423254 Completed - Gastric Cancer Clinical Trials

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Start date: February 2007
Phase: Phase 1
Study type: Interventional

The present clinical trial is a dose comparison of a multi-component active immunotherapy designed to stimulate an immune reaction to specific tumor associated antigens which are highly expressed on a large number of solid cancers.